# Marianne Brodmann

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marianne-brodmann/

## Facts

| Field | Value |
| --- | --- |
| Citations | 39,223 |
| Field | Peripheral Artery Disease Management |
| h-index | 59 |
| i10-index | 205 |
| Last Known Institution | Medical University of Graz |
| OpenAlex ID | https://openalex.org/A5076495125 |
| ORCID iD | https://orcid.org/0000-0001-6493-3799 |
| Works | 423 |

## Researcher papers

- [Rivaroxaban in Peripheral Artery Disease after Revascularization](https://scholariq.org/papers/rivaroxaban-in-peripheral-artery-disease-after-revascularization/)
- [2024 ESC Guidelines for the management of peripheral arterial and aortic diseases](https://scholariq.org/papers/2024-esc-guidelines-for-the-management-of-peripheral-arterial-and-aortic/)
- [The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation](https://scholariq.org/papers/the-role-of-vascular-biomarkers-for-primary-and-secondary-prevention-a-position/)
- [Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease](https://scholariq.org/papers/trial-of-a-paclitaxel-coated-balloon-for-femoropopliteal-artery-disease/)
- [The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society.](https://scholariq.org/papers/the-role-of-vascular-biomarkers-for-primary-and-secondary-prevention-a-position-2/)
- [2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias](https://scholariq.org/papers/2025-focused-update-of-the-2019-esc-eas-guidelines-for-the-management-of/)
- [Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication](https://scholariq.org/papers/editor-s-choice-european-society-for-vascular-surgery-esvs-2024-clinical/)
- [Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).](https://scholariq.org/papers/editor-s-choice-2017-esc-guidelines-on-the-diagnosis-and-treatment-of-peripheral/)
- [ESVM Guideline on peripheral arterial disease](https://scholariq.org/papers/esvm-guideline-on-peripheral-arterial-disease/)
- [Mortality Not Correlated With Paclitaxel Exposure](https://scholariq.org/papers/mortality-not-correlated-with-paclitaxel-exposure/)
- [Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease](https://scholariq.org/papers/stellarex-drug-coated-balloon-for-treatment-of-femoropopliteal-disease/)

## Researcher topics

- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)
- [Cerebrovascular and Carotid Artery Diseases](https://scholariq.org/topics/cerebrovascular-and-carotid-artery-diseases/)
- [Vascular Procedures and Complications](https://scholariq.org/topics/vascular-procedures-and-complications-2/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)

## Researcher university

- [Medical University of Graz](https://scholariq.org/institutions/medical-university-of-graz/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.